Europe — EMA
Oramorph (Morphine Sulfate Pentahydrate)
GNH USA supplies Oramorph (Morphine Sulfate Pentahydrate), an opioid analgesic for moderate to severe pain in adults. Request a quote for global supply.
International sale not permitted. Listed for the domestic market and B2B only.
Request sourcing
What is Morphine Sulfate Pentahydrate?
Morphine Sulfate Pentahydrate, the active ingredient in Oramorph, is an opioid analgesic presented as an oral formulation for oral administration. It is indicated for the management of moderate to severe pain and is commonly prescribed for adult patients requiring strong analgesia after surgery, injury, or in chronic pain conditions.
GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for this controlled Schedule II opioid and ensuring compliance with local regulations.
What is Morphine Sulfate Pentahydrate used for?
Oramorph, an opioid analgesic, is used to manage pain that involves the central nervous system.
Postoperative pain: provides relief after surgical procedures. Cancer pain: alleviates severe pain associated with malignant disease. Acute severe injury pain: controls intense pain resulting from trauma. Chronic severe non‑cancer pain: offers long‑term analgesia for conditions such as severe osteoarthritis.
What are the side effects of Morphine Sulfate Pentahydrate?
Oramorph may cause a range of adverse reactions, varying from mild to severe.
Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Sweating - Dry mouth - Itching
Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Hallucinations - Anaphylaxis or severe allergic reactions - Adrenal insufficiency - Withdrawal syndrome
What precautions apply to Morphine Sulfate Pentahydrate?
When prescribing Oramorph, clinicians should observe several safety measures.
Assess pain level: determine appropriate opioid therapy and baseline pain score. Monitor respiratory function: observe for signs of respiratory depression, especially after dose changes. Evaluate for constipation: implement prophylactic laxatives as needed. Avoid use in patients with severe respiratory disease: consider alternative analgesics. Check for drug dependence: assess history of substance abuse. Store at ambient temperature: keep in original container, protect from moisture and light.
What does Morphine Sulfate Pentahydrate interact with?
Oramorph interacts with several drug classes that may alter its safety or efficacy.
Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): additive respiratory depression. - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - Anticholinergic agents: increased risk of urinary retention. - Other opioids: risk of overdose.
Moderate Interactions (Monitor Closely): - SSRIs: potential for serotonin syndrome. - Diuretics: may enhance hypotensive effect. - Anticholinergics: may worsen constipation. - Alcohol: enhances sedative effects.



